Biological PCR Technology Market Forecast: From $14.65 Billion in 2024 to $28.93 Billion by 2034

The global biological PCR technology market size is calculated at USD 15.68 billion in 2025 and is expected to reach around USD 28.93 billion by 2034, growing at a CAGR of 7.04% for the forecasted period.

Ottawa, April 15, 2025 (GLOBE NEWSWIRE) -- According to Towards Healthcare research, the global biological PCR technology market size was valued at USD 14.65 billion in 2024 and is predicted to hit around USD 28.93 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research.

Get All the Details in Our Solutions – Download Brochure: https://www.towardshealthcare.com/download-brochure/5311

Biological PCR Technology Market Overview

A polymerase chain reaction (PCR) is a laboratory technique used to amplify DNA sequences. PCR uses a short synthetic DNA fragment called primers to choose a segment of the genome for amplification and synthesize DNA in multiple rounds. The major components of a PCR technique include DNA template, DNA polymerase, oligonucleotides primers, deoxyribonucleotide triphosphate, and buffer systems. Real-time PCR, nested PCR, multiplex PCR, quantitative PCR, and arbitrary primed PCR are the different types of PCR techniques.

The rising prevalence of chronic disorders such as infectious disorders necessitates screening and early detection of these disorders. This increases the use of biological PCR technology. Technological advancements drive the latest innovations in PCR technology, enhancing efficiency and efficacy. The increasing investments and collaboration promote the use of PCR technology. The growing genomics and proteomics research also contribute to market growth. PCR-based diagnostics have been increasingly adopted since the COVID-19 pandemic era.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Biological PCR Technology Market Trends

• Growing Research and Development Activities: PCR technology possesses versatile applications in numerous fields, such as medicine and forensic sciences. PCR is widely used for the analysis of gene expression and gene mapping. It is also used to compare the genomes of two organisms in genomic studies.
• Rising Genomics & Proteomics Research: The rising prevalence of genetic disorders boosts the market. PCR technology is used to test and monitor genetic disorders and facilitate gene synthesis. It is also used to identify potential biomarkers and protein targets involved in disease progression.
• Burgeoning Diagnostics Sector: Advancements in technology lead to the development of novel and more advanced diagnostics. Several molecular diagnostic tools are based on PCR technology for the rapid evaluation of disease and cost-effective analysis. They enable rapid and sensitive detection of pathogens, genetic mutations, or other target molecules.
  

Limitations & Challenges in the Biological PCR Technology Market

• Lack of Skilled Professionals: Numerous developing and underdeveloped countries have a lack of skilled professionals to handle complex PCR technology procedures. This affects the ultimate outcomes and may lead to false positives or false negatives.
• Extreme Sensitivity: PCR technology is extremely sensitive and to detect even a single copy of a gene. This is a major challenge as it can detect contaminate trace DNA or RNA fragments from a previous reaction or extraneous sources.
• High Cost: The high cost of maintenance of PCR equipment is necessary, which limits the affordability of several healthcare organizations and research laboratories, especially in low- and middle-income countries.
  

Get the latest insights on healthcare industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

Miniaturized PCR Device: A Market Opportunity

Ongoing research efforts focus on miniaturizing PCR devices to reduce overall costs and improve data quality. Miniaturization refers to scaling down the volume of a reaction mixture or assay in molecular biology. It uses less sample for the assay procedure while providing enhanced sensitivity and efficiency. Some studies report that miniaturized devices can reduce experimental costs by 75%. Miniaturization offers high-resolution genomic and NGS libraries and simplifies scaling of an assay from low throughput to high throughput.

The advancements in microfluidic technology create ample opportunities for the biological PCR technology market players to develop miniaturized PCR devices. Miniaturizing PCR technology expedites the speed of DNA amplification due to the high surface-to-volume ratio, smaller thermal capacity, and larger heat transfer. This technology also has the potential for parallel reactions and enhanced portability.

Regional Analysis

Increasing Investments Dominated North America

North America dominated the global market in 2024. Technological advancements and state-of-the-art research and development facilities are the major growth factors of the market in North America. Favorable government policies and increasing investments support the use of PCR technology. The growing focus on genomics and proteomics research in pharmaceutical and biotechnology development boosts the market. The presence of established pharmaceutical and biotechnology companies contributes to R&D funding. This encourages companies to develop novel PCR-based diagnostics, propelling the biological PCR technology market.

• United States: The National Human Genome Research Institute (NHGRI) supports PCR-based research through collaborations and funding. The FY2025 NHGRI’s Presidential Budget request for Genomic and Medicine is around $105.5 million, an increase of 0.4% from FY2023.
• Canada: In March 2025, the Government of Canada and Québec announced an investment of $305 million to improve access to new and existing drugs, support early diagnosis and screening, and advance Québec’s Action Plan on Rare Diseases 2023-2027.

Asia-Pacific is anticipated to grow at the fastest rate in the market during the forecast period. The rising prevalence of infectious disorders, genetic disorders, and other chronic disorders potentiate the need for PCR technology. The burgeoning pharmaceutical and biotechnology sectors augment the market. The rapidly changing demographics and the rising geriatric population increase the demand for personalized medicines. PCR-based diagnostics help healthcare professionals provide personalized medicines based on the patient’s conditions. The increasing healthcare expenditure favors the adoption of PCR technology in healthcare organizations, fueling the biological PCR technology market.

• China: The National Medical Products Administration regulates the approval of PCR-based diagnostics in China. The Chinese government supports PCR research through funding and various policies.
• India: The Indian government is focusing on providing preventive, curative, palliative, and rehabilitative healthcare. The Union Health Minister launched the Open Real-Time PCR Kit for Diagnosis of Pulmonary Tuberculosis, developed by Huwel Lifesciences, at the International Symposium on Health Technology Assessment (ISHTA 2025).

Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes—schedule a call today: https://www.towardshealthcare.com/schedule-meeting

Segmental Outlook

Product Type Insights

The reagents & consumables segment held a dominant presence in the biological PCR technology market in 2024. Some common reagents required for the PCR technique include primers, enzymes, and buffers. Numerous biotech companies sell reagents and consumables to help researchers refill their PCR technique requirements. This enables researchers to conduct PCR experiments in the laboratory through kits. They are comparatively affordable and easy to use for amplifying DNA fragments. This eliminates the need to pay for every experiment. They also enable researchers to perform multiple experiments simultaneously.

End-User Insights

The diagnostic laboratories segment led the global biological PCR technology market in 2024. The rising prevalence of chronic disorders increases the need for diagnosing the conditions. Patients mostly prefer diagnostic laboratories due to the presence of skilled professionals and specialized equipment to detect particul ar diseases. Several government organizations emphasize screening and early disease detection of numerous disorders, favoring the segment’s growth. PCR technology has proven to be highly accurate, sensitive, and precise in detecting microbes responsible for disease causation.

Top Companies in the Market

• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN
• ABBOTT
• Takara Bio Inc.
• Merck KGAA
• Bioneer Corporation
• ILLUMINA Inc.
• Promega Corporation
• Eppendorf S
  

Recent Breakthroughs

• In February 2025, Bio-Rad Laboratories announced the acquisition of Stilla Technologies to complement Bio-Rad’s existing Digital PCR portfolio and accelerate the development of next-generation Digital PCR solutions. The acquisition was made to expand the business into applied research and clinical diagnostics.
• In January 2025, QIAGEN announced a significant increase in the capabilities of the QIAcuity Digital PCR system (dPCR), with more than a twofold increase in the number of targets. The increased capabilities can overcome assay design challenges and analyze multiple targets from a single biological sample.

Browse More Insights of Towards Healthcare:

• Biologics CDMO Market Size: https://www.towardshealthcare.com/insights/biologics-cdmo-market-sizing
  
• Biological Safety Testing Products and Services Market Size: https://www.towardshealthcare.com/insights/biological-safety-testing-products-and-services-market-sizing
  
• Spine Biologics Market Size: https://www.towardshealthcare.com/insights/spine-biologics-market-sizing
  
• Cancer Biologics Market Size: https://www.towardshealthcare.com/insights/cancer-biologics-market-sizing
  
• Retinal Biologics Market Size: https://www.towardshealthcare.com/insights/retinal-biologics-market-sizing
  
• Biologics Market Size: https://www.towardshealthcare.com/insights/biologics-market-size
  
• Digital PCR Market Size: https://www.towardshealthcare.com/insights/digital-pcr-market-sizing
  
• Hemophilia Inhibitors Market Size: https://www.towardshealthcare.com/insights/hemophilia-inhibitors-market-sizing
  
• Breast Implants Market Size: https://www.towardshealthcare.com/insights/breast-implants-market-sizing
  
• High Concentration mAb Products Market Size: https://www.towardshealthcare.com/insights/high-concentration-mab-products-market-sizing

Segments Covered in the Report

By Product Type

• Reagents
• Consumables

By End-User

• Diagnostic Laboratories
• Molecular Testing Laboratories

By Region

• North America
  • US
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
• Europe
  • Germany
  • UK
  • France
  • Italy 
  • Spain
  • Sweden 
  • Denmark
  • Norway
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
    

To invest in our premium strategic solution and customized market report options, click here: https://www.towardshealthcare.com/price/5311

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.